Healthcare Newsletters

Issue	Date	Size	Main Topics
38	November 2014	175 KB	Abacavir-based regimens in patients with high viral loads Proton pump inhibitor, H2 receptor blocker and antacid drug interactions with atazanavir/ritonavir Update on the Mississippi child - a reality check Maraviroc A festive reflection
37	August 2014	161 KB	The EARNEST trial: new evidence regarding efficacy of second line ART regimens New drug profile: rilpivirine The value of a psychological report in treatment failure Clinical Case Report - 35 year old male patient on a PMB Medical Scheme Option (Subject to State Protocols)
36	December 2013	118 KB	Key principles in the management of patients with suspected drug-induced liver injury (DILI) while on TB treatment (with or without ART) The perinatally infected adolescent Rifabutin in HIV medicine Should one discontinue co-trimoxazole prophylaxis in children established on ART?
35	August 2013	131 KB	Fixed dose combination antiretrovirals containing TDF, FTC/3TC and efavirenz Combination induction therapy for cryptococcal meningitis Isoniazid preventive therapy for people on ART An approach to weight loss in HIV-infected patients World Health Organization raises the bar
34	April 2013	165 KB	Etravirine Potential Cure of HIV in an infant - The Mississippi child - What can we learn? Can we already change our practice? Use of Pre-Exposure Prophylaxis 20th Conference on Retroviruses and Opportunistic Infections
33	December 2012	217 KB	Practice Point - "Lipodystrophy" due to an unexpected drug interaction Timing of ART in patients with cryptococcal meningitis Abacavir or Tenofovir in 1^st line ART? A Festive Reflection
32	June 2012	126 KB	National Department of Health Guidelines on the Management of Drug-resistant TB Study of switching to atazanavir for lipodystophy Reporting Adverse Drug Reactions Tenofovir for children and adolescents
31	February 2012	121 KB	The conundrum of infant feeding for HIV infected women continues Tenofovir and aminoglycosides What if my patient's CD4 count does not rise on ART Isoniazid preventive therapy
30	November 2011	126 KB	Managing fat gain in patients on antiretroviral therapy TB treatment in patients on second-line ART Lopinavir/ritonavir and Congenital Adrenal Hyperplasia in exposed infants? Developments in HIV renal transplantation Report back from the Mind, Body, HAART Symposium - Integrating mental health into HIV care
29	June 2011	111 KB	ART for Prevention Cryptococcal Antigen Screening in Patients with CD4 <= 100
28	May 2011	121 KB	Efavirenz Dose for Paediatric Patients Raltegravir: What is the Place of the New Kid on the Block? When is the Optimal Time to Start ART in Patients with TB? Recent findings African RCT of Influenza Vaccination in HIV Shows Benefit and Safety
27	December 2010	121 KB	Pre-exposure prophylaxis CD4 counts and percentages in children ART resistance, genotype resistance testing and archiving Amphotericin B
26	October 2010	121 KB	Patients with poor adherence to first line ART (2 NRTIs + 1 NNRTI) who have a persistently non-suppressed viral load Antimalarial chemoprophylaxis and treatment Newer protease inhibitors do not cause diabetes
25	July 2010	161 KB	Single drug switch from stavudine (or zidovudine) to tenofovir Long term isoniazid preventive therapy for HIV-infected adults: new evidence Immunization and HIV in adults Immunization in HIV-infected children and adolescents - emerging perspectives in 2010
24	February 2010	173 KB	HIV and pandemic influenza; lessons learnt and what to expect? Differential Diagnoses to consider in a patient with suspended TB Using nevirapine-based are in patients with TB Use of Ritonavir(Norvir®) as single protease infibitor in fants and childern Discontinuation Notice: Kaletra® soft gel capsules
23	October 2009	168 kb	When is the best time to start antiretroviral therapy? Elective caesarean sections and HIV transmission Genotyping testing for antiretroviral resistance Use of STAVUDINE(D4T) as part of combination therapy Antibiotics to prevent STIs POST SEXUAL ASSAULT
22	April 2009	167 kb	Antiretrovirals and the liver Isoniazid (INH) prophylaxis for HIV-infected children Isoniazid preventive therapy for HIV-infected healthcare workers Risk factors for nephrotoxicity in patients on tenofovir Zidovudine (AZT) dose adjustment for infants Pneumonia in patients with HIV infection
21	January 2009	429 kb	Abacavir and the risk of myocardial infarction New insights in infant feeding – breast versus formula New Southern African HIV Clinicians Society Guidelines for Postexposure Prophylaxis Switching antiretrovirals for lipodystrophy
20	June 2008	209 kb	Antiretroviral therapy and the risk of myocardial infarction Aluvia tablets replace Kaletra Diagnosis of Mycobacterium Avium Complex (MAC) infection TDF (Tenofovir Disporoxil Fumarate) in special situations Antiretroviral resistance testing (genotyping)
19	February 2008	212 kb	Aid for AIDS Clinical Newsletter – Issue 19 Double-boosted protease inhibitor therapy for salvage ART: lack of evidence of benefit Diagnosing and treating smear negative and extrapulmonary Tuberculosis in HIV-infected patients Atazanavir in pregnancy Fluconazole and pregnancy Nutritional Management of the HIV positive patient “facts, fallacies and folk-lore” Monitoring patients on tenofovir – an update Completing the AfA application form
18	November 2007	html	Atazanavir Resistance mutations and atazanavir Early antiretroviral therapy (ART) in infants Hepatotoxicity when using adjusted dose Kaletra® with rifampicin Clinical, virological and immunological responses to HAART NNRTI vs boosted PI regimens
17	July 2007	146 KB	The use of Tenofovir Disoproxil Fumarate (TDF) in HAART regimens Resistance patterns associated with decreased tenofovir efficacy Emtricitabine (FTC) Tenofovir: Side effects and toxicities Hepatitis B The use of tenofovir in pregnancy and in paediatric patients Monitoring patients on tenofovir Viread® and Truvada® Tenofovir drug interactions
16	March 2007	110 KB	Contraception and antiretroviral therapy Monitoring lipids and glucose The SMART study Breast feeding in HIV-infected and exposed infants - paradigm shift Antiretroviral therapeutic drug monitoring Monitoring and promoting adherence to therapy with courier pharmacies
15	December 2006	14 KB	Dose of Stavudine Patients who Switch to Nevirapine with Higher CD4 Counts are not at Increased Risk of Hepatotoxicity Antiretroviral Resistance Testing Routine Testing for HIV Infection Post Exposure Prophylaxis (PEP) - Remember to Assess the Risks and Benefits Pneumococcal Vaccine for Children
14	June 2006	15 KB	Pro Forma Letter
14	June 2006	115 KB	Breastfeeding in HIV-Infected Infants Triomune-40 Tablets are Available Referring Patients to Public Sector ARV Clinics Bacterial Pneumonia in HIV+ Adults Using Kaletra with Rifampicin
13	January 2006	126 KB	AfA awarded the HIV Disease Management contract for GEMS Discontinuing fluconazole prophylaxis following cryptococcal meningitis Tenofovir plus didanosine (DDI) Switching stavudine (D4T) to an alterative agent
12	October 2005	146 KB	Management of Patients with Myperlactataemia / Lactic Acidosis Doses in Renal Failure Enteric Coated Videx Capsules Available HAART Hypertension
11	June 2005	59 KB	New AfA guidelines for initiating HAART in adults Management of isolated elevated Gamma Glutamyl Transpeptidase (GGT) levels in HIV WHO Clinical Stage III and IV conditions Treating PCP in patients who are allergic to Cotrimoxazole AfA Clinical Guildelines - 5th Edition
10	February 2005	71 KB	Management of HIV - Associated Kaposi's Sarcoma (KS) Generic Antiretrovirals ARVs) Scheme changes for 2005 FDA Public Health Advisory for Nevirapine
9	August 2004	62 KB	WHO clinical staging The role of Tenofovir DF (Viread) Protease inhibitor induced diarrhoea Benefit booking Making major decisions on CD4+ counts Tuberculosis and ART Generic antiretrovirals
8	April 2004	71 KB	Nevirapine and pregnancy - new concerns Immune "boosters" in HIV infection AfA and generic antiretroviral agents Increase in 0199 payment Scheme changes for 2004 Kaletra and Rifampicin HAART and Porphyria
7	November 2003	59 KB	Voluntary Counselling and Testing Non-nucleoside reverse transcriptase inhibitor in the internal regimen AfA and generic antiretroviral agents Death knell for structured treatment interruptions The Medscheme Price List (MPL)
6	August 2003	78 KB	New AfA criteria for initiating ART Pharmaceutical Courier Services ICU management of HIV patients HIV rapid testing
5	March 2003	55 KB	The role of nelfinavir (Vira-cept) Changing from dual NRTI therapy to HAART Guidelines for managing Lipid disorders Structured treatment interruptions
4	December 2002	81 KB	New guidelines for initiating Antiretroviral Therapy (ART) Scheme changes for 2003 Corrections to the 4th edition of the Clinical guidelines
3	September 2002	61 KB	CD4 counts for dummies Mother-to-Child prophylaxis
2	March 2002	60 KB	HIV VIral loads for dummies Peripheral neuropathy Dealing with Cotrimoxazole intolerance
1	August 2001	65 KB	Tuberculosis and antiretroviral therapy Testing for resistance to HIV drugs Intensifying antiretroviral therapy